Picture of Alkermes logo

ALKS Alkermes Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-197-111-48.2-158356
Depreciation
Deferred Taxes
Non-Cash Items12388.791.7122107
Unusual Items
Other Non-Cash Items
Changes in Working Capital65.413.1-25.512.7-36.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities72.182.810221401
Capital Expenditures-90.9-42.2-28-38.3-48
Purchase of Fixed Assets
Other Investing Cash Flow Items-50.930.7-38.2-26.3101
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-142-11.5-66.2-64.553.4
Financing Cash Flow Items-9.32-7.7-16.6-18.2-303
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6.76-2.1729.1-1.57-290
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-6369.264.6-45.1165